Abstract:Abstract BACKGROUNDS: Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by peripheral blood platelet count<100x10^9/L and increased risk of bleeding, but its exact pathogenesis remains unclear. Previous researches mostly emphasized on periphral blood, in order to elucidate the pathogenesis and provide new strategies for treatment, a series of studies about bone marrow B cells were carried out in our investigation. METHODS: 5ml bone marrow blood samples from 11 newly diagnosed ITP patients and 7 allo-HSCT healthy donors were collected into heparin anticoagulant tubes , bone marrow mononuclear cells (BMMCs) were separated with Ficoll density gradient-centrifugation in two hours. Different subsets of B lymphocytes were determined by multicolor flow cytometry including naive B cells, total memory B cells , plasma cells and regulatory B cells (Bregs) ,as well as some chemokine receptors of B cells (CXCR5, BAFFR, BCMA, TACI) . RNA were extracted from BMMCs using Trizol reagent, transcription factors related to development and differentiation of B cells (PRDM1, Pax5, IRF-4, XBP1) were detected by real-time PCR. RESULTS: The percentage of B cells (CD19+) in bone marrow lymphocytes in ITP patients was significantly lower than that in healthy donors (6.16±0.74% vs. 17.28±2.43%, P < 0.0001). The proportion of naive B (CD19+CD27-) in B cells was also lower compared with normal controls (59.11±7.60% vs. 81.58±4.00%, P=0.041), and the proportion of memory B (CD19+CD27+) was higher(40.17±7.67% vs. 18.01±3.89%, P=0.045),but there was no significant difference in plasma cells (CD19-CD138+). Besides,there was a decrease of Breg (CD19+CD24highCD38high) in ITP patients compared with healthy donors (20.33±5.05% vs. 57.98±9.76% , P = 0.008), and its percentage of total lymphocytes was also significantly lower unsurprisingly (1.38±0.38% vs. 12.23±2.88%, P < 0.001). The level of BAFFR in mature B cells was elevated in ITP patients (80.72±4.53% vs. 45.81±8.49%, P = 0.002). However, no significant difference was observed in other three chemokine receptors. All four Transcription factors related to B cell development and differentiation was not found to be significantly different between ITP patients and healthy controls. CONCLUSIONS: Our results showed that memory B cells which represent the active form were increased, and Bregs which mediate immune tolerance were much more decreased in ITP patients. As BAFFR is the only specific receptor of B cell activating factor(BAFF), its elevated expression suggested the BAFF-BAFFR system enhanced chemotactic function of B cells in ITP patients. All those results indicated that the bone marrow B cells in patients with ITP were in a state of immune overstimulation, this may potentially constitute a novel therapeutic target. Figure. Figure. Disclosures No relevant conflicts of interest to declare.

Abnormalities of regulatory T lymphocytes in primary immune thrombocytopenia

Changes in Follicular Helper T Cells in Idiopathic Thrombocytopenic Purpura Patients.

Treg Cell Abnormality and Its Potential Treatments in Patients with Primary Immune Thrombocytopenia

Aberrant Expression of NLRP3, NLRC4 and NLRP6 Inflammasomes in Patients with Primary Immune Thrombocytopenia

Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia

T Cells in the Pathogenesis of Immune Thrombocytopenia.

Abnormal Microenvironment of Bone Marrow B Lymphocytes in Patients with Primary Immune Thrombocytopenia

Advances in the pathophysiology of primary immune thrombocytopenia

[Alterations of CD4+ CD25+ Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura].

T Cell Immune Abnormalities in Immune Thrombocytopenia

The Ratio of Treg/Th17 Cells Correlates with the Platelet Number in Different Disease State of Primary Immune Thrombocytopenia

Abnormal Distribution and Function of Monocyte Subsets in Patients with Primary Immune Thrombocytopenia

Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Immune Thrombocytopenia.

Emerging role of stem cell memory-like T cell (TSCM) in immune thrombocytopenia.

Changes and mechanisms of Th9, Th17 and CD4+ CD25+ Foxp3+ regulatory T cells in the development of adult primary immune thrombocytopenia

Interleukin-7 is decreased and maybe plays a pro-inflammatory function in primary immune thrombocytopenia

Defective Early B Cell Tolerance in Primary Immune Thrombocytopenia

Alterative Expression Pattern of T Cell Immunosuppressive Receptors in Peripheral Blood of Patients with Itp

The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia.

[Advances of Research on Abnormality of Cell Immunity in Idiopathic Thrombocytopenic Purpura: Review].